"Designing Growth Strategies is in our DNA"

Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Product (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI100707



Play Audio Listen to Audio Version

The global nebulizer market size was USD 1.04 billion in 2020. The global impact of COVID-19 has been unprecedented and staggering, with the market growth witnessing a negative impact on demand across all regions amid the pandemic. Based on our analysis, the global market exhibited a lower growth of 15.33% in 2020. The market is projected to grow from USD 1.16 billion in 2021 to USD 1.93 billion in 2028 at a CAGR of 7.5% in the 2021-2028 period. The sudden fall in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.

A nebulizer is a drug delivery device that enables medication administration in the form of a mist into the lungs. These devices pump pressurized air through the liquid to form a fine mist, breathed in through a mouthpiece or mask. These machines are designed to treat asthma, asthma cystic fibrosis, COPD, and other respiratory disorders.

The rising incidence of respiratory disorders globally and the rising geriatric population are likely to fuel the market growth during the forecast period. Rising demand for innovative respiratory drug delivery devices and the rapid adoption of these devices among the patient population is likely to drive their usage during the forecast period.

Nebulizer amid COVID-19 Pandemic Shows Moderate Growth

Currently, the COVID-19 pandemic outbreak across the globe has accelerated the demand for devices to efficiently control the spread of this respiratory infection. As the coronavirus cases accelerate, many countries face a critical shortage of ventilators and meter dose inhalers. However, there are concerns raised on the safety profile of respiratory devices for transmission of the infection.

According to a recent report by the Asthma and Allergy Foundation of America (AAFA), when used on patients with COVID-19 in hospitals, these devices are likely to increase the risk of transmission of infections among patients as healthcare professionals. However, many pharmaceutical companies are focusing on developing effective therapies to treat the Covid- 19 infections, which will be chiefly administered via a nebulizer. For instance, In May 2021, Vectura and Inspira Pharmaceuticals announced a collaboration to develop a potential inhalation-based COVID-19 therapy. Vectura will test IPX formulation delivery to lungs through Vectura’s FOX vibrating mesh nebulizer through this agreement.

Furthermore, In December 2020, Ampio Pharmaceuticals Inc announced that it had started open enrollment for its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients. The Ampion in the clinical trial is administered using a handheld nebulizer to deliver the drug directly into the lungs. The generation of positive responses from the clinical study is anticipated to propel the market growth. Moreover, if medical device companies strongly emphasize the development of advanced devices in this segment that reduce the generation of aerosols, then there is a more substantial possibility of an upsurge in the growth of this market amid the coronavirus pandemic.


Request a Free sample to learn more about this report.

Strong Focus by Market Players on the Development of Highly Advanced Devices

Growing innovations and investments by market players to develop technologically advanced devices have played a significant role in increased accessibility to patients, healthcare providers, and other end users. For instance, Omron Healthcare, Inc. offers OMRON MicroAIR U100, a battery-operated portable device for treating respiratory conditions from a simple cough to asthma. The MicroAIR U100 has a 360-degree operation which enables its usage in any position and makes it highly comfortable for smaller children. Moreover, the device uses unique mesh technology to deliver the medication to the lungs effectively.

Additionally, In June 2020, Respira Technologies, Inc. launched the RespiRx nebulizer platform in the market. This new drug delivery platform is an ultra-portable handheld Vibrating Mesh Nebulizer (VMN) intended for local and systemic treatment. Such innovative devices are likely to accelerate the demand for these portable devices at a rapid pace. Rising awareness among healthcare providers about innovative products and the increase in collaborations among players to extend their market reach are anticipated to accelerate the market growth.


Increasing Incidence of Respiratory Disorders to Propel Market Growth

Asthma, Chronic Obstructive Pulmonary Disorder (COPD), and other respiratory conditions are exerting a huge economic burden on healthcare systems of various countries globally. There has been a rise in the prevalence of these conditions, owing to various factors including increase in smoking population, poor air quality, and so on. According to the Global Strategy for Diagnosis, Management and Prevention of COPD report, the European Union spends around 6% of its total healthcare budget on management of respiratory disorders (direct costs) each year. Also, according to the report, COPD accounts for roughly 60% of the total expenditure on respiratory diseases by the EU each year.

In emerging countries, the prevalence is gradually increasing which is resulting in a large number of patient suffering from respiratory disorders. Various government initiatives towards promoting early diagnosis and treatment, is leading to increasing number of patients undergoing treatment. This coupled with increasing introduction of new products in the market including nebulization devices, have been pivotal in driving the adoption of these devices. For instance, in 2020, Omron Healthcare introduced the ‘OMRON NE C106’, a cost effective and all-age-group compatible nebulization device in India.

Growing Demand for Home Healthcare Devices to Drive the Market

The rising cost of healthcare services and hospital stays has led to a shift in patient treatment towards home settings, thus increasing the adoption of breathable medical devices for home healthcare. Growing demand for effective inhaled drug delivery devices and the promotion of respiratory care devices for home use by many healthcare organizations are likely to boost the growth of this market during the forecast period.


Presence of Alternate Treatment Options to Restrict Market Growth

This is a mature market and is likely to face competition with a growing acceptance of substitute devices for treating respiratory disorders by patients. There is an increasing preference from healthcare providers towards inhalers, including metered-dose inhalers for asthma treatment. The clinical and operational benefits of MDIs in the treatment of asthma and the lower cost of these devices have witnessed a growing shift of patients from nebulization devices to inhalers. Moreover, limited reimbursement policies in developing economies and the higher costs of mesh are likely to hamper the market during the forecast period.


By Product Analysis

To know how our report can help streamline your business, Speak to Analyst

Jet Nebulizer to Hold Leading Position in Global Market

Based on product type, the market is segmented into the jet, mesh, and ultrasonic nebulizers.

Nebulization devices based on jet technology for delivering aerosolized medications have been used traditionally. The clinically proven technological advantages of jet devices, combined with comparatively lower costs, have been instrumental in higher adoption and demand for these devices globally. This combined with emergence of domestic manufacturers offering new and low-cost devices in this segment, especially in emerging countries is fueling the growth of the segment.

The mesh segment is expected to register a comparatively higher CAGR during the forecast period. Technological superiorities of mesh technology in aerosol drug delivery, along with R&D advances made by the manufacturers has led to growing preference towards these devices by patients and healthcare providers in developed countries. However, comparatively lower penetration of these devices in emerging countries owing to high cost, has limited the growth of the segment to a certain extent.

The ultrasonic segment is anticipated to have a steady growth. Limitations offered by ultrasound devices to aerosolize viscous solutions and drugs, along with other clinical and technological limitations have witnessed limited preference towards these devices especially in emerging countries. This combined with significantly higher cost of the devices is responsible for lower demand in emerging and developed countries.

By Modality Analysis

Portable Segment to Witness Significant Growth in Market during Forecast Period

In terms of modality, the market is segmented into portable and table-top.

The market is dominated by table-top devices, and this segment is expected to account for the largest nebulizer market share during the forecast period. Major factors contributing to the higher share of the segment include an increase in the usage of table-top due to operational benefits offered by these devices and the presence of a large number of players with a strong table-top nebulizer portfolio.

The portable segment is anticipated to witness substantial growth during the forecast period. Distinct features offered by these devices, including the small device size making it easy to use at home, are likely to increase the demand for these devices during the forecast period. The growing number of players in the development of portable devices and their rising adoption are likely to significantly boost the portable segment growth during the forecast period.

By End User Analysis

Homecare Setting Segment to Gain Popularity during Forecast Period

The market is segmented into hospitals, clinics, and home care settings in terms of end-user.

Hospitals segment dominated the global market in 2020. Higher demand for these devices from hospital settings, especially driven by higher number of inpatient admissions with co-morbid conditions, has been pivotal in higher demand for table-top and portable devices from these settings globally.

Clinics segment has witnessed a lackluster demand for nebulizers, owing to comparatively lower preference of patients towards receiving nebulization in clinics as compared to hospitals. This is augmented by the shift of patients towards home settings which has further limited the demand for these devices in clinics.

The shift of patients towards home settings, and introduction of new and portable devices, with comparatively lower costs has been pivotal in driving the demand for these devices from home care settings.


North America Nebulizer Market Size, 2020(USD Billion)

To get more information on the regional analysis of this market, Request a Free sample

The market size in North America stood at USD 0.35 billion in 2020. A higher prevalence of asthma, and other chronic respiratory conditions, along with rising adoption of advanced portable ones in the region, have been instrumental in a higher share of North America in the global market. According to the Centers for Disease Control and Prevention (CDC), every 1 in 13 people in the country has asthma. This equates to an estimated 25 million people in the United States suffering from asthma. Moreover, adequate reimbursement policies for these devices in the region are likely to boost the market growth in the region.

The market in Asia Pacific is driven by the rising prevalence of chronic respiratory diseases, improving healthcare infrastructure, and the growing number of medical device companies developing inhaled drug delivery devices to treat asthma and COPD. For example, In October 2020, HCmed Innovations Co., Ltd.., announced the launch of Pulmogine in China market. The product is a vibrating mesh nebulizer equipped with Micro Synchronized Delivery Technology (MSDT).

To know how our report can help streamline your business, Speak to Analyst

On the other side, the market in Latin America, and Middle East & Africa is likely to grow at a slower pace. The rapid rise in the prevalence of asthma and COPD is likely to accelerate the demand for these devices for the management of chronic respiratory diseases in the respective regions during the forthcoming years.


Presence of Innovative Devices Allows Players to Establish Strong Foothold in Market

The competitive landscape indicates the presence of a fragmented market. Omron Healthcare, Inc., Koninklijke Philips N.V., and PARI Respiratory Equipment, Inc. are among the top players in the market. The players are majorly focused on developing innovative devices and entering into strategic partnerships and collaborations to strengthen their position in this market.

Moreover, the market is further characterized by a large proportion of small manufacturers in the emerging nations focusing on developing relatively lower-cost devices. Other key players offering a wide range of devices involve DeVilbiss Healthcare LLC, BRIGGS HEALTHCARE, GF HEALTH PRODUCTS, INC., Trudell Medical International, Allied Healthcare Products, Inc., Teleflex Medical, Inc., and Others


  • OMRON Healthcare, Inc. (Kyoto, Japan)

  • Koninklijke Philips N.V. (Amsterdam, Netherlands)

  • PARI Respiratory Equipment, Inc. (Midlothian, VA, U.S.)

  • DeVilbiss Healthcare LLC (Pennsylvania, U.S.)

  • Briggs Healthcare (West Des Moines, U.S.)

  • GF HEALTH PRODUCTS, INC. (Georgia, U.S.)

  • Trudell Medical International (London, Canada)

  • Allied Healthcare Products, Inc. (Missouri, U.S.)

  • Teleflex Medical, Inc. (Pennsylvania, U.S.)


  • July 2020 – OMRON Healthcare, the leading Japanese player in home healthcare, announced the launch of OMRON NE C106. It is an addition to their compressor nebulizer portfolio. Company is continuously innovating in the area of respiratory medication delivery.

  • April 2020 - Asclepius Meditec Co. Ltd., a China-based medical device company, announced the development of AMS-H-03, an advanced hydrogen-oxygen nebulizer to relieve the shortage of ventilators in China for the treatment of COVID-19 patients.


An Infographic Representation of Nebulizers Market

To get information on various segments, share your queries with us

The global nebulizer market research report provides a detailed analysis of the market and focuses on key aspects such as technological advancements, the prevalence of asthma, and COPD. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation



Study Period


Base Year


Estimated Year


Forecast Period


Historical Period



Value (USD billion)


Product, Modality, End User

By Product

  • Jet Nebulizer

  • Ultrasonic Nebulizer

  • Mesh Nebulizer

By Modality

  • Portable

  • Table-top

By End-user

  • Hospitals

  • Clinics

  • Homecare Settings

By Geography

  • North America (By Product, By Modality, By End User, and By Country)

    • U.S. (By Product)

    • Canada (By Product)

  • Europe (By Product, By Modality, By End User, and By Country)

    • U.K. (By Product)

    • Germany (By Product)

    • France (By Product)

    • Italy (By Product)

    • Spain (By Product)

    • Rest of Europe (By Product)

  • Asia Pacific (By Product, By Modality, By End User, and By Country)

    • China (By Product)

    • Japan (By Product)

    • India (By Product)

    • Australia (By Product)

    • Southeast Asia (By Product)

    • Rest of Asia Pacific (By Product)

  • Latin America (By Product, By Modality, By End User, and By Country)

    • Brazil (By Product)

    • Mexico (By Product)

    • Rest of Latin America (By Product)

  • Middle East & Africa (By Product, By Modality, By End User, and By Country)

    • GCC (By Product)

    • South Africa (By Product)

    • Rest of Middle East & Africa & Africa(By Product)

Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 1.04 billion in 2020 and is projected to reach USD 1.93 billion by 2028.

In 2020, the market value stood at USD 1.04 billion.

Growing at a CAGR of 7.5%, the market will exhibit steady growth in the forecast period.

The jet segment is expected to be the leading segment type in this market during the forecast period.

Rising incidence of chronic respiratory diseases, increasing adoption of homecare medical devices, and growing advancements in these devices are some of the key factors driving the market.

Omron Healthcare, Inc., Koninklijke Philips N.V., and PARI Respiratory Equipment, Inc. are among the top players in the market.

North America dominated the market share in 2020.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Dec, 2021
  • 2020
  • 2017-2019
  • 150


  • $4850
    Buy Now

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.